levonorgestrel has been researched along with Antiphospholipid Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appenzeller, S; Bahamondes, L; Costallat, LTL; Fernandes, A; Pignaton, E; Rebelo, RC; Valeria Bahamondes, M | 1 |
| Bignoumba Ibouili, R; Boguikouma, JB; Coniquet, S; Iba Ba, J; Makanga, R; Mipinda, JB; Moussavou Kombila, JB | 1 |
2 other study(ies) available for levonorgestrel and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system.
Topics: Adult; Antiphospholipid Syndrome; Cohort Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lupus Erythematosus, Systemic; Retrospective Studies; Young Adult | 2019 |
[Purple extremities in black-skinned patients: blue toe syndrome as presenting sign of antiphospholipid antibody syndrome].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Biomarkers; Black People; Blue Toe Syndrome; Contraceptive Agents, Female; Diagnosis, Differential; Female; Humans; Ischemia; Levonorgestrel; Risk Factors; Toes | 2010 |